<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00925691</url>
  </required_header>
  <id_info>
    <org_study_id>RCB : 2008-A01027-48</org_study_id>
    <secondary_id>LOC / 05-12</secondary_id>
    <nct_id>NCT00925691</nct_id>
  </id_info>
  <brief_title>Comparison of SEPTal and Apical Pacing Sites in PerManent Right Ventricular Pacing</brief_title>
  <acronym>SEPTAL-PM</acronym>
  <official_title>Comparison of SEPTal and Apical Pacing Sites in PerManent Right Ventricular Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The SEPTAL-PM study is aimed to compare the right ventricular apical and right ventricular
      septal position of the right ventricular lead in patients implanted with a pacemaker for
      conventional anti-bradycardia pacing indications requiring permanent right ventricular pacing
      ; the primary endpoint is the evolution of the left ventricular ejection fraction assessed by
      contrast echocardiography at 18-months follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Classically the right ventricular pacing (RV) lead position is the RV apex. Several small
      studies suggested that the septal position which provided a more physiological conduction
      pattern would improve left ventricular function and dimensions and the patients' outcome.

      The SEPTAL-PM study is a parallel randomized prospective simple-blinded and multicenter
      national study with a follow-up duration of 18 month. A total of 180 patients will be
      enrolled.

      It was designed to demonstrate that in patients requiring permanent RV pacing for high degree
      atrio-ventricular conduction disorders the septal pacing would preserve the LVEF and LV
      dimensions but also the quality of life and the exercise tolerance.

      The primary endpoint is the evolution of the LVEF assessed by contrast echocardiography. The
      secondary endpoints are: the quality of life SF 36 questionnaire, the NYHA class, the
      6-minute-walk test, the QRS duration, the LV end-systolic and diastolic volumes, the NT-pro
      BNP, MMP 2-9 and TIMP-1 dosages, stimulation and detection ventricular thresholds.

      Other reported parameters are: the probes position and electric parameters, all causes of
      mortality, cardiovascular mortality, hospitalisations for cardiovascular causes, serious
      adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Left ventricular ejection fraction</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire SF 36</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NYHA class</measure>
    <time_frame>1, 6, 12, 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute-walk test</measure>
    <time_frame>1, 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LV end-systolic and diastolic volumes</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QRS duration,</measure>
    <time_frame>1, 6, 12, 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of cardiac remodeling markers: MMP2-9 and TIMP-1 and NT-pro BNP dosage</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All causes and cardiovascular mortality, hospitalizations for cardiovascular cause</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serious adverse events</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stimulation and detection ventricular thresholds</measure>
    <time_frame>1, 6, 12, 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probes position and electric parameters</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">141</enrollment>
  <condition>Atrioventricular Block</condition>
  <arm_group>
    <arm_group_label>APICAL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>implantation at the apex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SEPTAL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>implantation at the interventricular septum</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RV lead</intervention_name>
    <description>The RV lead is implanted at the apex or at the interventricular septum</description>
    <arm_group_label>APICAL</arm_group_label>
    <arm_group_label>SEPTAL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years old.

          -  Written informed consent.

          -  Permanent cardiac pacing indication for high degree AV block with ventricular rate
             less than 50 bpm according to the current guidelines of the European Society of
             Cardiology .

          -  Patients with sinus rhythm or permanent atrial fibrillation.

        Non-inclusion Criteria:

          -  Indication for cardiac resynchronization.

          -  Indication for Intra cardiac defibrillators (ICD).

          -  Indication for AV node ablation for patients with atrial fibrillation.

          -  Patients already implanted with a pacemaker or an ICD.

          -  Myocardial infarction within the previous month.

          -  Surgically treated valvulopathy.

          -  Tricuspid Valve prothesis

          -  Cardiac surgery or coronary revascularization planned or within the 3 last months.

          -  Life expectancy less than 18 months.

          -  Pregnancy.

          -  Disability to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christophe Leclercq, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU d'Angers</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de cardiologie-CHU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de cardiologie-CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2009</study_first_submitted>
  <study_first_submitted_qc>June 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 22, 2009</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrioventricular Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

